Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tigerlabs is a Princeton, New Jersey-based private venture platform that combines coworking space, entrepreneurship support, and an early-stage investment fund. Historically, the organization has operated a digital health accelerator and has also invested more broadly in early-stage software companies spanning services, internet of things, advertising and media, education, enterprise, fintech, ad tech, and digital health. The business is not a drug developer, biotech company, or healthcare services operator; rather, it supports startups through workspace, community, mentorship, and seed-stage investing. Its Tigerlabs Ventures fund has invested in dozens of companies, but the fund is no longer seeking new investment opportunities. For life sciences diligence purposes, Tigerlabs is best categorized as a startup investor/accelerator with some digital health exposure rather than a therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tigerlabs.